The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.
November 20th 2024
The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Ultrasound provides noninvasive assessment of vocal fold lesions
December 26th 2007Laryngeal ultrasound can provide useful diagnostic information about benign lesions of the vocal folds. Unlike other assessment methods, it is noninvasive and inexpensive and requires no anesthesia or radiation.
Corporate and academic R&D target stroke with ultrasound
December 20th 2007Philips is working with contrast agent developer ImaRx to find information that might turn diagnostic ultrasound scanners into weapons against acute ischemic stroke, the companies announced early this month. Research at Oregon Health & Science University may complement Philips’ collaboration, providing information to use against a disease with annual medical costs approaching $63 billion.
Corporate and academic R&D target stroke with ultrasound
December 20th 2007Philips is working with contrast agent developer ImaRx to find information that might turn diagnostic ultrasound scanners into weapons against acute ischemic stroke, the companies announced early this month. Research at Oregon Health & Science University may complement Philips’ collaboration, providing information to use against a disease with annual medical costs approaching $63 billion.
Bedside ultrasound shows placement of pediatric endotracheal tubes
December 17th 2007Bedside ultrasound quickly and accurately verifies the placement of endotracheal tubes in pediatric patients, even when the standard tests give false-negative or equivocal results, according to a recent study.
Contrast-enhanced ultrasound shows new marker for atherosclerosis
December 10th 2007Contrast-enhanced ultrasound of the carotid artery can identify the presence and degree of vascularization in atherosclerotic plaque, providing a noninvasive way to measure the existence and degree of atherosclerosis, according to a recent study.
Report from RSNA: Radiologists, sonologists say, ‘Don’t pull plug on contrast ultrasound’
December 4th 2007An overwhelming majority of the audience at an RSNA special focus session voted in favor of keeping up the efforts to get FDA approval for the use of contrast ultrasound for general radiology applications.
Ultrasound-guided injections control recurrent papillary thyroid carcinoma
December 3rd 2007Ultrasound-guided percutaneous ethanol injections hold up as a treatment for controlling neck recurrence of papillary thyroid carcinoma. They could be effective for patients who are poor candidates for surgery.
Breast ultrasound boosts detection, benign biopsies
December 1st 2007Breast ultrasound significantly increases detection of cancers in high-risk women but takes a big toll in the rate of benign biopsies, according to the initial results of a screening trial sponsored by the American College of Radiology Imaging Network and the Avon Foundation.
Accuvix V10 joins Medison portfolio
November 30th 2007Medison America spotlights the Accuvix V10 this week at the RSNA meeting. The ultrasound scanner, which appeared last year as a work-in-progress, cleared the FDA in spring. It supports 3D/4D imaging, as well as spectral, color, and power Doppler.
Palmheld and handheld join Siemens ultrasound
November 30th 2007The palm-sized Acuson P10 ultrasound scanner appears this week as a commercial product from Siemens Medical Solutions along with the laptop-based Acuson P50. The P50 is designed for mobile environments but is outfitted with diagnostic-level capabilities, including high-quality gray-scale as well as color and Doppler imaging. Its primary applications will be in cardiology and vascular imaging.
Three-D transducers enhance Toshiba ultrasound
November 30th 2007Toshiba America Medical Systems upgraded its Xario XG and Aplio ultrasound sytems with three transducers, each capable of volumetric scanning. The additions expand the range of these systems, which previously had depended on only one transducer for 4D imaging. The transducers can be applied to transvaginal/obstetric, prostate, small parts including breast, testes, and thyroid, and abdominal scanning.
Radiologists, sonologists say, ‘Don’t pull the plug on contrast ultrasound’
November 30th 2007An overwhelming majority of the audience at an RSNA special focus session Thursday voted in favor of keeping up the efforts to get FDA approval for the use of contrast ultrasound for general radiology applications.
Ingested fish bones can cause a school of problems
November 29th 2007Radiologists must become more alert to the extensive range of health problems faced by patients who swallow fish bones, according to a thought-provoking poster from Spain that was one of eight international exhibits to scoop a prestigious Magna Cum Laude award in the vast RSNA 2007 poster hall on Wednesday afternoon.
Hitachi debuts flagship ultrasound
November 29th 2007The hierarchy of ultrasound systems at Hitachi Medical Systems America has a new flagship. Particularly noteworthy on the HI Vision 900 is an elastographic capability that characterizes pathologies based on ultrasonic measurements of the relative stiffness of tissue.
Siemens introduces high-end ultrasound class
November 29th 2007The S-2000 ultrasound scanner, takes shape this week as a new commercial product at the high end of the Siemens Medical Systems’ ultrasound portfolio. The S-2000, cleared by the FDA in mid-October, does not replace the Sequoia, Siemens’ flagship since it acquired ultrasound pioneer Acuson six years ago. Instead, it complements the system, according to Siemens executives, by combining best-of-breed technologies from Sequoia with Siemens’ ultrasound platforms developed prior to the Acuson acquisition.
Performance data help justify breast MRI’s whopping price tag for high-risk screening
November 28th 2007MRI has outrun other modalities in a screening trial involving high-risk women. Such research helps justify an estimated $1.4 billion a year in direct costs for the U.S. if new American Cancer Society guidelines are followed.
Report from RSNA: Imaging techniques fine-tune upper extremity MSK diagnoses
November 28th 2007MR arthrography and ultrasound bring different strengths to imaging and management of joint injuries and stresses, according to research presented at the RSNA meeting. Contrast-enhanced ultrasound is a superior method of assessing neovascularity in patients with lateral epicondylitis, while MR can detect signs of recurrent carpal tunnel syndrome after surgery. A combination of MRI and ultrasound may be the most effective solution for imaging medial elbow pain.
Imaging techniques fine-tune upper extremity MSK diagnoses
November 27th 2007Magnetic resonance arthrography (MRA) and ultrasound bring different strengths to imaging and treating joint injuries and stresses, according to research presented at the RSNA meeting. Contrast-enhanced ultrasound is a superior method of assessing of neovascularity in patients with lateral epicondylitis, while MR can detect signs of recurrent carpal tunnel syndrome after surgery. A combination of MRI and ultrasound may be the most effective solution for imaging medial elbow pain.
Transcranial ultrasound diagnoses restless legs syndrome
November 26th 2007Transcranial B-mode sonography can be used as a test to identify restless legs syndrome, a difficult condition to diagnose. Doctors previously relied on a patient’s description of unmeasurable symptoms. Exams showed hypoechogenic substantia nigra, red nucleus, and brain stem raphe.